Research articleExhaustive computational search of ionic-charge clusters that mediate interactions between mammalian cytochrome P450 (CYP) and P450-oxidoreductase (POR) proteins
Introduction
The cytochromes P450 (CYP, EC 1.14.14.1) are a superfamily of heme-thiolate enzymes that catalyze the monooxygenation of hydrophobic endogenous and xenobiotic substrates (Bridges et al., 1998). CYP homologs have been sequenced from all lineages of life—including eukaryotes and bacteria (Sevrioukova et al., 1999b, Zawaira et al., 2008). The cytochrome P450 enzymatic cycle includes substrate binding, first electron transfer, oxygen binding, second electron transfer, substrate oxidation and finally, product dissociation. Hence the CYP reaction cycle involves two distinct electron transfer steps (Bridges et al., 1998, Kuznetsov et al., 2006). Biologically relevant CYP-catalyzed monooxygenation reactions include steroid metabolism and biogenesis, xenobiotic metabolism, fatty acid metabolism and antibiotic metabolism (Sevrioukova et al., 1999b). Bacterial CYPs are soluble proteins that have high substrate specificity while their mammalian cousins are endoplasmic reticulum-bound CYPs mostly involved in xenobiotic metabolism and have broad substrate specificity (Nelson and Strobel, 1987). Despite these differences, surveys of known CYP structures from across the different lineages of life show that the CYP structure/fold is highly conserved (Hasemann et al., 1995, Sansen et al., 2007, Schoch et al., 2004, Wester et al., 2004, Yano et al., 2004). A notable feature of this highly conserved CYP fold architecture is that a proximal surface, where the heme cofactor comes closest to the protein surface, can readily be discerned from the distal surface where the heme group is farthest from the protein surface (Hasemann et al., 1995, Poulos et al., 1987, Sansen et al., 2007, Schoch et al., 2004, Wester et al., 2004, Yano et al., 2004).
The cytochrome P450 enzyme sources electrons from redox partner systems. Bacterial and mitochondrial CYPs obtain catalytic cycle electrons from small soluble iron–sulfur electron transport proteins such as adrenodoxin (also known as ferredoxin-1, FDX1) and putidaredoxin (Sevrioukova et al., 1999b). On the other hand, mammalian microsomal CYPs source their electrons from NADPH dependent P450-oxidoreductase (POR). POR contains the flavin cofactors FAD and FMN (Sevrioukova et al., 1999b). POR is organised into four domains which are, from the protein N-terminus to the C-terminus, the FMN binding domain, the connecting domain, the FAD binding domain and the NADPH-binding domain (Wang et al., 1997). The FAD cofactor accepts electrons from NADPH and transfers them to the FMN cofactor, which in turn, transfers electrons to the heme iron of substrate-bound CYP (Sevrioukova et al., 1999b, Wei et al., 2007).
An important question in CYP research is the elucidation of the protein–protein interactions involved in the process of electron transfer from redox partners to substrate-bound CYP. Following the determination of the first structure of a CYP (CYP450Cam from Pseudomonas putida) in 1985 (Poulos et al., 1985), the most parsimonious answer to that question would have been: CYP is likely to interact with redox partners at the proximal side where the heme centre is most easily accessible. Early models for the CYP–POR complex supported the parsimonious view (Stayton et al., 1989).
The current mainstream views on CYP–POR interaction surfaces ultimately trace their origins to the studies on the reduction of cytochrome c by cytochrome b5 (Stonehuerner et al., 1979). Stonehuerner et al. (1979) showed that the interaction between cytochrome c and cytochrome b5 is mediated by complementary electrostatic interactions between specific lysine residues on cytochrome c and specific acidic residues (aspartate or glutamate) on cytochrome b5. Similar experiments have been performed demonstrating the role of electrostatic interactions in mammalian CYP–POR (Bernhardt et al., 1988, Davydov et al., 2000, Kelley et al., 2005).
Extensions from the cytochrome c–cytochrome b5 model system to CYP target systems by Poulos and co-workers (1989) and by Davydov et al. (1992) provided the first information about CYP–redox partner interfacial residues. Poulos and co-workers’ extensions to the bacterial putidaredoxin–CYP450Cam system suggested that the P450Cam residues Arg112, Lys344 and Arg364 formed salt bridges with putidaredoxin residues Glu48, Glu44 and Asp60 respectively (Stayton et al., 1989). The P450Cam residues Arg112, Lys344 and Arg364 are homologous to CYP2B4 residues Arg125, Lys421 and Arg443 (Bridges et al., 1998). Davydov et al. (1992) extensions to the CYP2B4–P450-oxidoreductase system suggested that CYP2B4 positions 121–145 are involved in POR recognition.
Several other workers have contributed to the identification of CYP–redox partner interfacial residues. These include Juvonen et al. (1992) who showed the involvement of Arg129 in the binding of CYP2A5 to cytochrome b5. Bridges et al. (1998) delimited the following CYP2B4 residues as CYP2B4–POR interfacial residues: R122, R126, R133, F135, K433, R422 and R443. Shen and Kasper (1995) searched for surface exposed acidic clusters within the FMN-binding domain of POR and identified two interfacial residue clusters comprising 207D, 208D and 209D and 213E, 214E and 215D. Zhao et al. (1999) identified the cluster comprising 142D, 144D and 147D.
Of the bacterial redox systems that have been used as model systems to address the problem of redox partner recognition in mammalian systems, the cytochrome P450-BM3 bears the closest resemblance to mammalian systems. Flavocytochrome P450-BM3 is a 119 kDa self-sufficient fatty-acid monooxygenase from Bacillus megaterium. The protein consists of a heme domain (BMP) and a FMN/FAD-containing P450-oxidoreductase domain linked together in a single polypeptide chain (Sevrioukova et al., 1999b). Sevrioukova et al., 1999a, Sevrioukova et al., 1999b have determined the structure of a P450-BM3 construct comprising the heme/FMN-containing domain and it has been debated whether this structure is a plausible prototypical representation of a specific electron transfer complex.
Here we investigate the relationship between CYP2B4–POR interfacial residues one can delimit using the P450-BM3 structure as template and those which have been delimited to date by the many various experimental approaches listed above. We have also used our model of the CYP2B4–POR complex to implement an exhaustive search for oppositely charged clusters mediating the ionic interactions between mammalian CYP and POR. Comparison of our pairings with Karyakin's experimentally delimited pairings (Karyakin et al., 2007) has been used to validate our assignments.
Section snippets
Sequences and structures
Sequences were retrieved from the Universal Protein Resource Knowledgebase (UniProtKB/Swiss-Prot) database via the European Bioinformatics Institute website (http://www.ebi.ac.uk). The accession numbers were according to the UniProtKB database unless otherwise stated. Structures were retrieved from the RCSB Protein Data Bank (www.pdb.org). The sequence accession numbers used herein are as follows. CYP1A1: P04798 (Homo sapiens), CYP1A2: P05177 (H. sapiens), CYP2B1: P00176 (Rattus norvegicus) and
Structural model for the CYP2B4–P450-oxidoreductase FMN-binding domain complex
The structural model for the CYP2B4–POR FMN-binding domain complex is shown in Fig. 1. CYP–redox partner residues described in the literature are projected onto this model. This generates a (qualitative) visual representation of the relationship between the interface delimited by adopting the structure by Sevrioukova et al. (1999b) (1BVY.pdb) as the prototypical CYP–redox partner interface and the set of interfacial residues delimited by various experimental approaches described in the
Discussion
Sevrioukova and co-workers have debated the biological significance of the CYP450BM-3 heme domain–CYP450BM-3 FMN-domain binding complex they determined (1BVY.pdb). While electrophoretic analysis of dissolved crystals revealed that the linker between the heme and the FMN-binding domain was proteolyzed (resulting in an asymmetric unit consisting of two heme domain molecules and only one FMN-binding domain), there are aspects of the structure of the complex that made it plausible it could
Conflict of interest
No conflict of interest declared.
Acknowledgements
A.Z., N.B.-K., and L.C. wish to thank the National Research Foundation (NRF) of South Africa for financial support through bursaries. J.B. wishes to thank the South African Research Chair Initiative (SARChI) for a research chair. M.G. wishes to thank the National Bioinformatics Network (NBN) of South Africa for funding.Author contributions are as follows: A.Z. and J.B. designed research; A.Z., M.G., L.C., N.B.-K., M.K. and P.M. performed research; A.Z., M.G., L.C. and N.B-K. analyzed data;
References (56)
- et al.
Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase
J. Biol. Chem.
(1998) - et al.
Role of LYS271 and LYS279 residues in the interaction of cytochrome P4501A1 with NADPH-cytochrome P450 reductase
Arch. Biochem. Biophys.
(2001) - et al.
Cytochrome C (Fe2+) as a competitive inhibitor of NADPH-dependent reduction of cytochrome P450 LM2: locating protein–protein interaction sites in microsomal electron carriers
Arch. Biochem. Biophys.
(1992) - et al.
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Structure
(1995) - et al.
Strength and co-operativity of contributions of surface salt bridges to protein stability
J. Mol. Biol.
(1990) - et al.
Rapid refinement of protein interfaces incorporating solvation: application to the docking problem
J. Mol. Biol.
(1998) - et al.
Multiple sequence alignment with Clustal X
Trends Biochem. Sci.
(1998) - et al.
FTIR studies of the redox partner interaction in cytochrome P450: the Pdx-P450cam couple
Biochim. Biophys. Acta
(2007) - et al.
Development of unified statistical potentials describing protein–protein interactions
Biophys. J.
(2003) - et al.
Contribution of surface salt bridges to protein stability: guidelines for protein engineering
J. Mol. Biol.
(2003)